moyamoya disease
Conditions
Interventions
Case series:Aspirin
Sponsors
Beijing Tiantan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
8 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. has been diagnosed with moaymoya disease (using the MRA/DSA); 2. signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. has aneurysm, AVM, intracranial tumor, hydrocephalus or intracranial hemorrhage; 2. allergic to contrast medium.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients with the 2-year new vascular events, defined as any event of the following: Any stroke (ischemic or hemorrhage) [ Time Frame: at 7days, 1months,3 months, 6 months, 12 months, 18 months, 24 months or end of trial]; | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients with the 2-year new clinical vascular events (ischemic stroke/ hemorrhagic stroke/ TIA/ MI/ vascular death) as a cluster and evaluated individually. [ Time Frame:at 7days, 1months,3 months, 6 months, 12 months, 18 months, 24 months or end of trial ];Modified Rankin Scale score changes (continuous) and dichotomized at percentage with score 0-2 vs. 3-6 at 2 year follow-up [ Time Frame: at 7days, 1months,3 months, 6 months, 12 months, 18 months, 24 months or end of trial ]; | — |
Countries
China
Contacts
Public ContactJizong Zhao
Beijing Tiantan Hospital, Capital Medical University
Outcome results
None listed